PETCT Metabolic Imaging In Tumour Boards – A Primer for Physicians.

Abu Dhabi, AZ AE
November 8, 2025

PET-CT Metabolic Imaging in Tumor Boards – A Primer for Physicians is a focused, one-day CME-accredited program designed to strengthen the role of radiologists and nuclear medicine physicians in multidisciplinary cancer care. This course offers a practical introduction to the principles and clinical applications of PET-CT in oncology, with a specific focus on how metabolic imaging informs decision-making within tumor board settings.

Participants will explore key oncologic indications, interpretative challenges, and patterns of disease response and progression through PET-CT. The program emphasizes the value of radiologic input in guiding treatment pathways, staging and restaging, and evaluating therapy response across a range of tumor types.

We shall review non-oncological indications of PETCT including neuro, cardiac and endocrine applications and explore imaging algorithms.

Combining didactic lectures with real-world case reviews and multidisciplinary discussions, this activity equips radiologists with the foundational knowledge and confidence needed to contribute meaningfully to tumor board deliberations and optimize patient outcomes through advanced metabolic imaging.

Target Audience

 

  • Radiologists
  • Nuclear Medicine Physicians
  • Technologists
  • Medical Residents
  • Interns
  • Students

Learning Objectives

 

By the end of this activity, participants will be able to:

  • Enhance their understanding of the principles and clinical applications of PET-CT in oncologic imaging.
  • Identify the appropriate isotopes, key indications, and strategies for optimal utilization of PET-CT in cancer care.
  • Interpret PET-CT findings with greater accuracy, recognizing patterns of disease and therapy response across various tumor types.
  • Promote quality assurance and patient safety through standardized imaging protocols and multidisciplinary collaboration.

Additional Information

Course summary
Available credit: 
  • 7.25 AMA PRA Category 1 Credit

    Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Cleveland Clinic Abu Dhabi designates this Live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
06/17/2025
Course expires: 
11/08/2025
Event starts: 
11/08/2025 - 8:00am +04
Event ends: 
11/08/2025 - 5:00pm +04
Rating: 
0
Hospital Ballroom
Al Maryah Island
Abu Dhabi, AZ 112
United Arab Emirates

Venue is located in Cleveland Clinic Abu Dhabi, Level P2, Ballroom

The planning committee, faculty, and others in control of content (either individually or as a group) have disclosed relevant financial relationships with ineligible companies. All relevant financial relationships have been reviewed and mitigated in accordance with ACCME standards.

Course Director(s)

Hidayath Ansari, MD, MRCP, FRCR

has no relevant financial relationships to disclose at this time.
Speaker(s)

Batool Al Balooshi, Consultant

has no relevant financial relationships to disclose at this time.

Hussain Al Khalifah, Hussain Al Khalifah MD

has no relevant financial relationships to disclose at this time.

Mazin Al-Janabi, Qualification MSC and PhD (Nuclear Medicine) (University of London) (FRCP)London

has no relevant financial relationships to disclose at this time.

Haluk Alibazoglu, Diplomate of ABNM and CBNC

has no relevant financial relationships to disclose at this time.

Muhammad Alkaphoury, MD, DABR, ABNM, CBNC

has no relevant financial relationships to disclose at this time.

Mahmoud El-Kaissi

has no relevant financial relationships to disclose at this time.

Safieeldin Ghazala, MD, FRCR

has no relevant financial relationships to disclose at this time.

Karsten Grabski

has no relevant financial relationships to disclose at this time.

Mohamed Halim Zaki, MB Chb, CCT Radiology, CCT Nuclear Medicine, MSc Nuclear Medicine (King's College London)

has no relevant financial relationships to disclose at this time.

Available Credit

  • 7.25 AMA PRA Category 1 Credit

    Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Cleveland Clinic Abu Dhabi designates this Live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Diamond Sponsor

Novartis is a leading, global healthcare company headquartered in Basel, Switzerland. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has a heritage of innovation that spans more than 250 years.

Our purpose is: “Reimagine medicine to improve and extend people’s lives.”  We are committed to delivering high-value medicines to address serious disease burdens, underpinned by technology leadership in research & development, and broad access-approaches.

Novartis’ global footprint spans over 118 countries with more than 78,000 employees and their medicines reach nearly 300 million patients worldwide.

With a focus on core therapeutic areas including oncology, immunology, cardiovascular disease and advanced platform technologies (such as gene and cell therapies), Novartis remains at the forefront of healthcare innovation.

 

 

Gold Sponsor

 

 

Modawina Medical Company (MMC) is a leading healthcare solutions provider based in the UAE, established in 2010. As a trusted regional partner to top international manufacturers, MMC delivers an extensive portfolio of advanced medical-equipment and technology solutions across radiology, nuclear medicine, surgical instruments, medical oncology, laboratory diagnostics, physiotherapy and rehabilitation. 

With over 20 years of collective experience in the GCC and a client base covering more than 50 healthcare facilities, MMC is committed to elevating patient care through innovative products, reliable service and customer-first support. Their recent strategic partnership with SHINE Technologies for distribution of the non-carrier-added lutetium-177 isotope in the UAE further underscores their commitment to cutting-edge nuclear medicine and targeted cancer therapies.

We are proud to welcome Modawina Medical Company as a sponsor of the PET/CT Imaging Workshop at Cleveland Clinic Abu Dhabi and appreciate their support in advancing imaging excellence and innovation in healthcare.

 

 

 

Established in 1989, Zahrawi Group is a pioneer Medical Devices and Life Science Distributor in the Gulf region, with a presence in UAE, KSA, Qatar, Oman, and Bahrain. Zahrawi Group is specialized in Surgical, Medical, Nuclear Medicine, Diagnostic, and Analytical Lab solutions, and was founded with a vision to be the leading and most trusted partner in the GCC.

Zahrawi Group is committed to improving people’s lives by introducing innovative Healthcare products, Smart solutions, and Outstanding services.

 

Silver Sponsor

 

 



 

Bayer Radiology is a global leader in diagnostic imaging, providing innovative solutions that empower healthcare professionals to deliver accurate diagnoses and improve patient outcomes. As part of Bayer Pharmaceuticals, the Radiology division focuses on developing and delivering contrast media, medical devices, and advanced digital health solutions for radiology practices worldwide.

Bayer offers a comprehensive portfolio of gadolinium-based and iodine-based contrast agents for MRI, CT, and angiography.

Key products include:

Gadovist®: A high-concentration macrocyclic gadolinium-based contrast agent for MRI.

Ultravist®: A non-ionic contrast medium for CT and X-ray imaging.

Primovist®: A liver-specific MRI contrast agent.

MEDRAD® Injection Systems

Bayer provides state-of-the-art injection systems designed to ensure precision and safety during contrast administration. Bayer is at the forefront of integrating AI and digital technologies into radiology workflows through platforms like:

Calantic™ Digital Solutions: AI-powered tools for enhanced radiological decision-making.

Workflow and data management systems to streamline imaging and reporting.

Research & Development:

Bayer invests heavily in R&D, focusing on improving imaging accuracy and developing next-generation contrast agents. Emphasis on AI, precision imaging, and patient-centric innovation.

Commitment to Sustainability:

Bayer is committed to environmental sustainability through initiatives to reduce the environmental impact of contrast media waste and promote safer disposal practices. Focused on creating sustainable solutions for healthcare that align with Bayer’s 2030 sustainability goals.

Key Differentiators:

Innovation-Driven: Bayer leverages cutting-edge technologies, such as AI and machine learning, to enhance diagnostic accuracy.

Patient Safety: Known for high-quality contrast agents like Gadovist, designed with excellent safety profiles and superior diagnostic performance.

Global Expertise: Bayer combines global expertise with localized support to meet diverse healthcare needs.

Collaboration with Radiologists: Bayer partners with radiologists to optimize imaging protocols and enhance diagnostic workflows.

Mission Statement: To advance medical imaging through innovation, precision, and partnership, enabling healthcare professionals to deliver better outcomes for patients worldwide.

 

 

Cyclomedical International is a distinguished provider of comprehensive nuclear-medicine solutions and PET facility services with a global footprint. Established in the United States, the company has extended its expertise into the Gulf region—including the UAE, Qatar, and Oman—managing and consulting on cyclotron production, site planning, regulatory compliance, and facility operations

Their mission: to integrate business, technical and regulatory functions seamlessly so that lifesaving imaging technology can improve patient outcomes. With decades of experience operating radiopharmaceutical production sites and serving PET imaging clinics, Cyclomedical stands out as a trusted partner when it comes to achieving high-standards in safety, performance and efficiency. 

Please login or register to take this course.

 

Click 'Continue' to complete your registration